# US 2026/0085343 A1 · Method for ligating nucleic acid fragments, method for constructing sequencing library, and use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085343 A1
- Document ID: US20260085343A1
- Status: Published application
- Kind: A1
- Application number: 19/340,794
- Filed: 2025-09-25
- Published: 2026-03-26
- Earliest claimed: 2018-08-07
- Assignees: Genemind Biosciences Company Limited
- Applicants: Genemind Biosciences Company Limited
- Inventors: Guangli GAN; Qunting LIN; Yunyang CHENG; Meng ZHANG; Gailing LI; Qin YAN; Luyang ZHAO
- Web page: https://patentgrep.com/patent/US20260085343A1

## CPC

- C12N 15/1093: {General methods of preparing gene libraries, not provided for in other subgroups}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed are a method for ligating nucleic acid fragments, a method for constructing a sequencing library, and the use thereof. The method for ligating nucleic acid fragments includes ligating a first nucleic acid fragment and a second nucleic acid fragment in a mixed enzyme reaction system including a DNA ligase and an RNA ligase, wherein the first nucleic acid fragment is double-stranded DNA. The ligation efficiency of the method for ligating nucleic acid fragments can reach 85% or more, and by using this ligation method to construct a sequencing library, the yield of the effective library is significantly improved.

## Claims

### Claim 1

A method for nucleic acid fragment ligation, comprising:
ligating a first nucleic acid fragment and a second nucleic acid fragment in a mixed enzyme reaction system comprising a DNA ligase and an RNA ligase, wherein the first nucleic acid fragment is a double-stranded DNA.

### Claim 2 (depends on 1)

The method as claimed in claim 1, wherein the mixed enzyme reaction system further comprises a polynucleotide kinase, wherein the DNA ligase is selected as a T4 DNA ligase, the RNA ligase is selected as a T4 RNA ligase, and the polynucleotide kinase is selected as a T4 polynucleotide kinase.

### Claim 3 (depends on 1)

The method as claimed in claim 1, wherein the first nucleic acid fragment is a phosphorylated nucleic acid fragment.

### Claim 4 (depends on 2)

The method as claimed in claim 2, wherein the polynucleotide kinase is used to perform a phosphorylation treatment.

### Claim 5 (depends on 1)

The method as claimed in claim 1, wherein the second nucleic acid fragment is a double-stranded nucleic acid fragment.

### Claim 6 (depends on 5)

The method as claimed in claim 5, wherein the second nucleic acid fragment comprises sequences of SEQ ID No. 1 and 2, and SEQ ID No. 3 and 4.

### Claim 7 (depends on 6)

The method as claimed in claim 6, wherein SEQ ID No. 1 has a modified amino group at the 5′ end, SEQ ID No. 2 has a modified phosphate group at the 5′ end, SEQ ID No. 3 has a modified amino group at the 5′ end, and SEQ ID No. 4 has a modified phosphate group at the 5′ end.

### Claim 8 (depends on 6)

The method as claimed in claim 6, wherein SEQ ID No. 1 and 2, and SEQ ID No. 3 and 4 are in a molar ratio of 1:1.

### Claim 9 (depends on 1)

The method as claimed in claim 1, wherein a molar ratio of the first nucleic acid fragment to the second nucleic acid fragment is 1:8 to 1:20.

### Claim 10 (depends on 9)

The method as claimed in claim 9, wherein the molar ratio of the first nucleic acid fragment to the second nucleic acid fragment is 1:10.

### Claim 11 (depends on 2)

The method as claimed in claim 2, wherein a final concentration of the RNA ligase in a ligation reaction system is 0.15 U/μL to 1 U/μL.

### Claim 12 (depends on 11)

The method as claimed in claim 11, wherein a final concentration of the polynucleotide kinase in a phosphorylation system is 0.3 U/μL to 1 U/μL.

### Claim 13 (depends on 2)

The method as claimed in claim 2, further comprising:
mixing the first nucleic acid fragment, the second nucleic acid fragment, the T4 polynucleotide kinase, the T4 DNA ligase, and the T4 RNA ligase for 20-40 min at 10-20° C. to obtain a ligation product.

### Claim 14 (depends on 1)

The method as claimed in claim 1, further comprising: subjecting DNA fragment in a mixed enzyme system consisting of a T4 polynucleotide kinase and a T4 DNA ligase buffer to a reaction for 20-40 min at 35-40° C. to give an intermediate product, and co-incubating the intermediate product and an adapter in a mixed enzyme system consisting of a T4 DNA ligase, a T4 RNA ligase, and a T4 DNA ligase buffer for 20-40 min at 10-20° C. to give a ligation product.

### Claim 15 (depends on 9)

The method as claimed in claim 9, wherein an amount of the first nucleic acid fragment is calculated using formula (I):
pmols
=
m
*
10
3
660
*
L
,
(
I
)
wherein
m is a weight of the first nucleic acid fragment, in ng,
L is a length of the first nucleic acid fragment, in bp; and
an amount of the second nucleic acid fragment is calculated using formula (II):
pmols
=
C
*
V
,
(
II
)
wherein
C is a molar concentration of the second nucleic acid fragment, in μM,
V is a volume of the second nucleic acid fragment, in μL.

### Claim 16 (depends on 1)

A method for constructing a sequencing library, comprising:
acquiring a ligation product by the method as claimed in claim 1, to obtain the sequencing library, wherein the first nucleic acid fragment is from a sample under test.

### Claim 17 (depends on 16)

A sequencing method, comprising:
acquiring a sequencing library using the method as claimed in claim 16, and sequencing the sequencing library.

### Claim 18 (depends on 1)

A kit configured for performing the method as claimed in claim 1.

### Claim 19 (depends on 18)

The kit as claimed in claim 18, comprising a DNA ligase, an RNA ligase, and a package insert of the kit describing the method for ligation.
